CD274 and neoplasm: In combination with anti-PD-L1 antibody therapy, the self-assembled core-shell nanosystem loaded with oxaliplatin and dihydroartemisinin can effectively induce T cell activation and reduce inhibitory cell infiltration in a mouse colorectal tumor model, thereby achieving a lasting enhancement of anti-tumor immunity (173).